GPCR stock

Structure Therapeutics Inc. American Depositary Shares (GPCR) financials · $1.09B cap

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Structure Therapeutics Inc. American Depositary Shares (GPCR) $1.09B cap.

Cached annual income statement
LineFY2025FY2024
Operating Income-$176.6M-$158.2M
Net Income-$141.2M-$122.5M
EPS (Diluted)-$0.80-$0.78
Cached annual balance sheet
LineFY2025FY2024
Total Assets$1.58B$903.3M
Current Assets$1.57B$891.2M
Cash & Equivalents$799.6M$169.5M
PP&E$6.65M$3.48M
Total Liabilities$67.5M$38.5M
Current Liabilities$63.3M$36.0M
Shareholders' Equity$1.52B$864.8M
Retained Earnings-$470.3M-$329.1M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$222.2M-$116.6M
CapEx$3.61M$1.29M
Investing Cash Flow$89.8M-$358.9M
Financing Cash Flow$762.5M$515.3M
Net Change in Cash$630.1M$39.7M
Free Cash Flow-$225.8M-$117.9M
These statements as JSON? API free 100/day

FAQ

What is GPCR P/E and revenue?

Structure Therapeutics Inc. American Depositary Shares (GPCR) $1.09B cap.

What is GPCR revenue?

GPCR income-statement cache has no revenue figure yet.

Is GPCR profitable?

Structure Therapeutics Inc. American Depositary Shares last cached net income is -$141.2M (FY2025).

What are GPCR total assets?

Structure Therapeutics Inc. American Depositary Shares last cached total assets are $1.58B (FY2025).

What is GPCR free cash flow?

Structure Therapeutics Inc. American Depositary Shares last cached free cash flow is -$225.8M (FY2025).

Not investment advice. Cached statements, not a live tape.